ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 38 filers reported holding ATYR PHARMA INC in Q2 2022. The put-call ratio across all filers is 10.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,310,066 | -26.9% | 4,626,624 | -0.0% | 2.43% | -32.6% |
Q2 2023 | $9,994,804 | -1.4% | 4,627,224 | -4.1% | 3.60% | +6.1% |
Q1 2023 | $10,134,016 | +462.1% | 4,825,722 | +703.0% | 3.40% | +319.1% |
Q3 2022 | $1,803,000 | +5.9% | 600,980 | -0.1% | 0.81% | +2.4% |
Q2 2022 | $1,702,000 | -47.1% | 601,580 | 0.0% | 0.79% | -40.7% |
Q1 2022 | $3,218,000 | -18.0% | 601,580 | +14.5% | 1.34% | -25.9% |
Q4 2021 | $3,926,000 | +5.3% | 525,531 | +28.0% | 1.80% | +6.2% |
Q3 2021 | $3,728,000 | – | 410,535 | – | 1.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tikvah Management LLC | 1,225,833 | $9,157,000 | 2.55% |
Stonepine Capital Management, LLC | 525,531 | $3,926,000 | 1.80% |
Telemetry Investments, L.L.C. | 176,782 | $1,321,000 | 1.70% |
TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $8,317,000 | 1.67% |
VR Adviser, LLC | 1,565,000 | $11,691,000 | 1.60% |
Deep Track Capital, LP | 1,100,000 | $8,217,000 | 0.58% |
EAM Investors, LLC | 252,280 | $1,885,000 | 0.31% |
EAM Global Investors LLC | 152,792 | $1,141,000 | 0.20% |
FEDERATED HERMES, INC. | 5,222,250 | $39,010,000 | 0.07% |
Alyeska Investment Group, L.P. | 674,975 | $5,042,000 | 0.06% |